UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported) September 16, 1996
CHANTAL PHARMACEUTICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-13304 22-2276346
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
12121 Wilshire Boulevard, Los Angeles, California 90025
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (310) 207-1950
<PAGE>
Item 4. Changes at Registrant's Certifying Accountant
---------------------------------------------
On September 16, 1996, the Registrant engaged BDO Seidman, LLP. as the
Registrant's independent certified public accountant to report on the Company's
financial statements for the fiscal year ended June 30, 1996, and the financial
statements of Registrant's 90% owned subsidiary Chantal Skin Care Corporation
for the year ended June 30, 1996. In the past two years and any interim period,
neither the Registrant nor its 90% owned subsidiary have consulted with BDO
Seidman, LLP. on the application of accounting principles or the type of audit
opinion or any other matter.
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CHANTAL PHARMACEUTICAL CORPORATION
----------------------------------
(Registrant)
By: /s/ CHANTAL BURNISON
-------------------------------
Chantal Burnison
Chairman and Chief Executive Officer
Dated: September 23, 1996
